Stratos Wealth Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,873	Closed	-$309K	–	1254
2022 Q2	$309K	Sell	3,873 -821	-17%	-$77.7K	0.01%	920
2022 Q1	$494K	Sell	4,694 -874	-16%	-$85.2K	0.01%	818
2021 Q4	$600K	Buy	5,568 +38	+0.7%	+$4.14K	0.01%	743
2021 Q3	$606K	Buy	5,530 +159	+3%	+$16.5K	0.02%	689
2021 Q2	$503K	Sell	5,371 -1,226	-19%	-$113K	0.01%	770
2021 Q1	$607K	Sell	6,597 -639	-9%	-$53.9K	0.02%	653
2020 Q4	$529K	Sell	7,236 -2,392	-25%	-$178K	0.02%	660
2020 Q3	$748K	Buy	+9,628	New	+$662K	0.02%	493
2018 Q4	–	Sell	-2,000	Closed	-$39K	–	2932
2018 Q3	$39K	Buy	+2,000	New	+$38K	﹤0.01%	1572
2018 Q2	–	Sell	-2,750	Closed	-$39K	–	3017
2018 Q1	$39K	Sell	2,750 -5,300	-66%	-$78.3K	﹤0.01%	1705
2017 Q4	$118K	Buy	+8,050	New	+$113K	0.01%	1095